TP53 and breast carcinoma: Notably, andrographolide, a key component, has demonstrated its efficacy in inducing apoptosis in TD-47 human breast cancer cells by elevating p53, the Bcl-2-associated protein X (Bax), and caspase 3 levels while concurrently suppressing Bcl-2 expression [26].